Company: MIRA
Filing Date: 2025-09-11
Form Type: 8-K
Source: 0001493152-25-013100
Chunk: 2

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-09-11
Form: 8-K
Item: Item 5.02
Chunk 2
---
holders approved the ratification of the appointment of Salberg & Company, P. A. as the Company’s independent
registered public accounting firm for the fiscal year ending December 31, 2025, based upon the voting results set forth below.

   Votes For      Votes Against      Votes Abstained      Broker Non-votes  
 ────────────────────────────────────────────────────────────────────────────
  10,488,635             22,121               77,454      -                 

Proposal
4

The
Company’s stockholders approved amendments to the 2022 Omnibus Incentive Plan, based upon the voting results set forth below:

  Votes For      Votes Against      Votes Abstained      Broker Non-votes  
 ───────────────────────────────────────────────────────────────────────────
  5,292,099            573,124              115,162             4,607,826  

Proposal
5

The
Company’s stockholders approved a proposal to approve an adjournment of the Annual Meeting, if necessary, to solicit additional
proxies if there are not sufficient votes in favor of Proposals 1 and/or 4 was withdrawn because the Company’s stockholders approved
and adopted the Proposal 1 and 4, as noted above, based on the voting results set forth below.

  Votes For      Votes Against      Votes Abstained      Broker Non-votes  
 ───────────────────────────────────────────────────────────────────────────
  6,037,027            302,474              165,895             4,082,815  

Item
9.01 Financial Statements and Exhibits.